Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Journal of Infection Année : 2021

Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study

Dates et versions

hal-03858469 , version 1 (17-11-2022)

Identifiants

Citer

Jean-Philippe Kevorkian, Amanda Lopes, Damien Sène, Jean-Pierre Riveline, Claire Vandiedonck, et al.. Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study. Journal of Infection, 2021, 82 (6), pp.276-316. ⟨10.1016/j.jinf.2021.02.008⟩. ⟨hal-03858469⟩
12 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More